naion with tirzepatide Ophthalmic Complications Observed After Use of GLP-1 Agonists naion and tirzepatide GLP-1 RAs
Description
Share this post Weight loss More articles
Switching between GLP-1 medications is generally safe, but your healthcare provider should oversee the transition to ensure appropriate dosing and timing
However, Zepbound is not approved for use in children or adolescents
Important Medical Disclaimer: This medication requires medical supervision
Participants receiving the highest dose (1.0 mg) achieved a mean weight loss of 10.6%, while those in the placebo group experienced a mean weight loss of only 2%
